Pembrolizumab‐induced benign atypical intralymphatic CD30+ T‐cell proliferation mimicking intravascular lymphoma

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of dermatology 2022-02, Vol.49 (2), p.e53-e54
Hauptverfasser:	Hung, Wei‐Kai, Chen, Chun‐Bing, Kuo, Tseng‐tong, Chen, Wei‐Ti
Format:	Artikel
Sprache:	eng
Schlagworte:	Antibodies, Monoclonal, Humanized CD30 antigen Cell Proliferation Humans Ki-1 Antigen Lymphocyte Activation Lymphoma Mimicry Pembrolizumab
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	e54
container_issue	2
container_start_page	e53
container_title	Journal of dermatology
container_volume	49
creator	Hung, Wei‐Kai Chen, Chun‐Bing Kuo, Tseng‐tong Chen, Wei‐Ti
description
doi_str_mv	10.1111/1346-8138.16166
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2577452979</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2577452979</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3956-9483ab5db165b185319f3b437e941bca7d7a07ce3f905254ea7993431ab7cfe13</originalsourceid><addsrcrecordid>eNqFkc1OxCAUhYnR6PizdmeauDExVShQytLM-BsTXeiaAKWKlnaEVjOufASf0SeRWnXhxrshuXzn5OQeALYRPEBxDhEmeVogXBygHOX5Epj8bpbBBOKCphmBbA2sh_AAYcYpgqtgDRNaQI7oBHTXxinf1va1d1J9vL3bpuy1KRNlGnvXJLJbzK2WdWKbzst64eb3srM6mc4w3E9uokCbuk7mg0VlfPxrm8RZZ_Wjbe5G1bMMuq-lT77krZObYKWSdTBb3-8GuD05vpmepZdXp-fTo8tUY07zlJMCS0VLhXKqUEEx4hVWBDPDCVJaspJJyLTBFYc0o8RIxjkmGEnFdGUQ3gB7o2-M99Sb0Alnw5BXNqbtg8goY4RmnPGI7v5BH9reNzGdyPKMEF5wzCJ1OFLatyF4U4m5t076hUBQDIWI4fxiOL_4KiQqdr59e-VM-cv_NBABOgIvtjaL__zExex4NP4EwK-X3Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2624498937</pqid></control><display><type>article</type><title>Pembrolizumab‐induced benign atypical intralymphatic CD30+ T‐cell proliferation mimicking intravascular lymphoma</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Hung, Wei‐Kai ; Chen, Chun‐Bing ; Kuo, Tseng‐tong ; Chen, Wei‐Ti</creator><creatorcontrib>Hung, Wei‐Kai ; Chen, Chun‐Bing ; Kuo, Tseng‐tong ; Chen, Wei‐Ti</creatorcontrib><identifier>ISSN: 0385-2407</identifier><identifier>EISSN: 1346-8138</identifier><identifier>DOI: 10.1111/1346-8138.16166</identifier><identifier>PMID: 34580915</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>Antibodies, Monoclonal, Humanized ; CD30 antigen ; Cell Proliferation ; Humans ; Ki-1 Antigen ; Lymphocyte Activation ; Lymphoma ; Mimicry ; Pembrolizumab</subject><ispartof>Journal of dermatology, 2022-02, Vol.49 (2), p.e53-e54</ispartof><rights>2021 Japanese Dermatological Association</rights><rights>Copyright © 2022 Japanese Dermatological Association</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3956-9483ab5db165b185319f3b437e941bca7d7a07ce3f905254ea7993431ab7cfe13</citedby><cites>FETCH-LOGICAL-c3956-9483ab5db165b185319f3b437e941bca7d7a07ce3f905254ea7993431ab7cfe13</cites><orcidid>0000-0002-1929-4008</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2F1346-8138.16166$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2F1346-8138.16166$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34580915$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hung, Wei‐Kai</creatorcontrib><creatorcontrib>Chen, Chun‐Bing</creatorcontrib><creatorcontrib>Kuo, Tseng‐tong</creatorcontrib><creatorcontrib>Chen, Wei‐Ti</creatorcontrib><title>Pembrolizumab‐induced benign atypical intralymphatic CD30+ T‐cell proliferation mimicking intravascular lymphoma</title><title>Journal of dermatology</title><addtitle>J Dermatol</addtitle><subject>Antibodies, Monoclonal, Humanized</subject><subject>CD30 antigen</subject><subject>Cell Proliferation</subject><subject>Humans</subject><subject>Ki-1 Antigen</subject><subject>Lymphocyte Activation</subject><subject>Lymphoma</subject><subject>Mimicry</subject><subject>Pembrolizumab</subject><issn>0385-2407</issn><issn>1346-8138</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1OxCAUhYnR6PizdmeauDExVShQytLM-BsTXeiaAKWKlnaEVjOufASf0SeRWnXhxrshuXzn5OQeALYRPEBxDhEmeVogXBygHOX5Epj8bpbBBOKCphmBbA2sh_AAYcYpgqtgDRNaQI7oBHTXxinf1va1d1J9vL3bpuy1KRNlGnvXJLJbzK2WdWKbzst64eb3srM6mc4w3E9uokCbuk7mg0VlfPxrm8RZZ_Wjbe5G1bMMuq-lT77krZObYKWSdTBb3-8GuD05vpmepZdXp-fTo8tUY07zlJMCS0VLhXKqUEEx4hVWBDPDCVJaspJJyLTBFYc0o8RIxjkmGEnFdGUQ3gB7o2-M99Sb0Alnw5BXNqbtg8goY4RmnPGI7v5BH9reNzGdyPKMEF5wzCJ1OFLatyF4U4m5t076hUBQDIWI4fxiOL_4KiQqdr59e-VM-cv_NBABOgIvtjaL__zExex4NP4EwK-X3Q</recordid><startdate>202202</startdate><enddate>202202</enddate><creator>Hung, Wei‐Kai</creator><creator>Chen, Chun‐Bing</creator><creator>Kuo, Tseng‐tong</creator><creator>Chen, Wei‐Ti</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1929-4008</orcidid></search><sort><creationdate>202202</creationdate><title>Pembrolizumab‐induced benign atypical intralymphatic CD30+ T‐cell proliferation mimicking intravascular lymphoma</title><author>Hung, Wei‐Kai ; Chen, Chun‐Bing ; Kuo, Tseng‐tong ; Chen, Wei‐Ti</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3956-9483ab5db165b185319f3b437e941bca7d7a07ce3f905254ea7993431ab7cfe13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Antibodies, Monoclonal, Humanized</topic><topic>CD30 antigen</topic><topic>Cell Proliferation</topic><topic>Humans</topic><topic>Ki-1 Antigen</topic><topic>Lymphocyte Activation</topic><topic>Lymphoma</topic><topic>Mimicry</topic><topic>Pembrolizumab</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hung, Wei‐Kai</creatorcontrib><creatorcontrib>Chen, Chun‐Bing</creatorcontrib><creatorcontrib>Kuo, Tseng‐tong</creatorcontrib><creatorcontrib>Chen, Wei‐Ti</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hung, Wei‐Kai</au><au>Chen, Chun‐Bing</au><au>Kuo, Tseng‐tong</au><au>Chen, Wei‐Ti</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pembrolizumab‐induced benign atypical intralymphatic CD30+ T‐cell proliferation mimicking intravascular lymphoma</atitle><jtitle>Journal of dermatology</jtitle><addtitle>J Dermatol</addtitle><date>2022-02</date><risdate>2022</risdate><volume>49</volume><issue>2</issue><spage>e53</spage><epage>e54</epage><pages>e53-e54</pages><issn>0385-2407</issn><eissn>1346-8138</eissn><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>34580915</pmid><doi>10.1111/1346-8138.16166</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-1929-4008</orcidid></addata></record>
fulltext	fulltext
identifier	ISSN: 0385-2407
ispartof	Journal of dermatology, 2022-02, Vol.49 (2), p.e53-e54
issn	0385-2407 1346-8138
language	eng
recordid	cdi_proquest_miscellaneous_2577452979
source	MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects	Antibodies, Monoclonal, Humanized CD30 antigen Cell Proliferation Humans Ki-1 Antigen Lymphocyte Activation Lymphoma Mimicry Pembrolizumab
title	Pembrolizumab‐induced benign atypical intralymphatic CD30+ T‐cell proliferation mimicking intravascular lymphoma
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T02%3A18%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pembrolizumab%E2%80%90induced%20benign%20atypical%20intralymphatic%20CD30+%20T%E2%80%90cell%20proliferation%20mimicking%20intravascular%20lymphoma&rft.jtitle=Journal%20of%20dermatology&rft.au=Hung,%20Wei%E2%80%90Kai&rft.date=2022-02&rft.volume=49&rft.issue=2&rft.spage=e53&rft.epage=e54&rft.pages=e53-e54&rft.issn=0385-2407&rft.eissn=1346-8138&rft_id=info:doi/10.1111/1346-8138.16166&rft_dat=%3Cproquest_cross%3E2577452979%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2624498937&rft_id=info:pmid/34580915&rfr_iscdi=true